Investor Announcements - 2014

Pages:

Result of Open Offer

10^th Apr 2014

The open offer to qualifying participants has been over-subscribed.

Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB.

20^th Mar 2014

EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers.

Final results for the year ended 31 December 2013

26^th Feb 2014

EKF Diagnostics announces its audited final results for the year ended 31 December 2013, a year of strong organic growth and improved earnings.

Pages:

Archive

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.